Stay updated on Ampyra Optic Neuritis in MS Clinical Trial

Sign up to get notified when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ampyra Optic Neuritis in MS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a Locations section with Missouri as a study site, replacing the previous Missouri Locations block. The HHS Vulnerability Disclosure link was removed, and the page revision is updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T14:50:50.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2 (site maintenance/update). No study content, endpoints, or eligibility criteria were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:50:29.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Removed the government funding notice that warned updates may not be up to date and that operations could be affected; the page no longer displays the NIH Clinical Center operating status guidance.
    Difference
    0.4%
    Check dated 2025-11-18T07:32:56.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page; the content appears unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:02:40.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Major update to page status: announces a funding lapse impact and that the NIH Clinical Center is open, plus a new version v3.2.0; removes the old v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:11:45.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Page now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.
    Difference
    0.3%
    Check dated 2025-09-29T04:43:36.000Z thumbnail image

Stay in the know with updates to Ampyra Optic Neuritis in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.